Products
| Product Name | CAS No. | Specification | Application | Registration |
| Trastuzumab (anti-HER2) | 180288-69-1 | 95+% | Antineoplastic Agent | |
| Cetuximab (C225) | 205923-56-4 | 95+% | Antineoplastic Agent | |
| Brefeldin A (BFA) | 20350-15-6 | 98+% | ||
| Verteporfin (CL 318952) | 129497-78-5 | 95+% | ||
| Vitamin D4 | 511-28-4 | 98+% | ||
| Ercalcitriol (1α,25-Dihydroxyvitamin D2) | 60133-18-8 | 98+% | ||
| Etanercept | 185243-69-0 | 95+% | ||
| Ansamitocin P-3 (Ansamitocin P 3) | 66584-72-3 | |||
| Capsiate | 205687-01-0 | |||
| Abiraterone Ethyl Ether (AB-IMP-12) | 2484719-14-2 | 98+% | ||
| Abiraterone Isopropyl Ether (AB-IMP-13) | 2484719-15-3 | 98+% | ||
| 7-Epi-Paclitaxel (7-Epitaxol) | 105454-04-4 | 98+% | Paclitaxel EP Impurity E | N/A |
| Cidofovir Dihydrate | 149394-66-1 | 98+% | ||
| Epothilone B (Patupilone) | 152044-54-7 | 98+% | Antineoplastic Agent | |
| Gemcitabine Hydrochloride | 122111-03-9 | 98+% | Antineoplastic Agent |
Products
Custom Synthesis-High Value-Added Advanced Pharmaceutical Intermediates
E-Mail: sales (at)Chemleader.com.cn
E-Mail: sales (at)Chemleader.com.cn